New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
14:02 EDTPCRXPacira Pharmaceuticals reports positive results from studies of EXPAREL
Pacira Pharmaceuticals announced new data evaluating the use of EXPAREL to manage postsurgical pain following total joint arthroplasty, which included hip and knee replacement surgery. The data, derived from two studies presented at the 81st annual meeting of the American Academy of Orthopedic Surgeons, demonstrated the benefits of EXPAREL in improving a variety of key post-TJA outcomes including pain management, incidence of accidental falls, opioid consumption and hospital stay/costs. The AAOS 2014 meeting is being held in New Orleans from March 11-15.
News For PCRX From The Last 14 Days
Check below for free stories on PCRX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for PCRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use